Janet Macpherson (she/her)

Passionate about #CellTherapy #GeneTherapy #womeninstem Tweets are my opinion. Retweets are not endorsement #WeAreCytiva
and #getvaxxed #getboosted

[Janet Macpherson (she/her) @jmacpher]

@BLLPHD @DrPHanley @ISCTglobal @carlhjune @PennMedicine @ChildrensPhila Absolutely the best news.
Well deserved Bruce.
Honoured to count you as one of those who first welcomed me to ISHAGE and cell therapy.

[Janet Macpherson (she/her) @jmacpher]

@theAGCTS meeting is in Sydney next week.
Looking forward to reconnecting with Cell and Gene Therapy colleagues. See you there?
#AGCTS

[The Australasian Gene and Cell Therapy Society @theAGCTS]

Abstract submission deadline for the 13th Biennial AGCTS meeting extended to 30/08/2024. Please register and submit abstracts via our website: https://t.co/uXnb8MfkEU

[Janet Macpherson (she/her) @jmacpher]

Join n-Lorem Foundation's 2024 Nano-Rare Patient Colloquium. This year’s colloquium will bring together patients, physicians, and supporters to create a cohesive, empathetic, and knowledgeable nano-rare community.
This event is open to all—register now! https://t.co/fp5SjKaotK

[Janet Macpherson (she/her) @jmacpher]

A new study describes the use of artificial intelligence (AI) in designing a new generation of capsids, the structures that envelop genetic material of adeno-associated viruses (AAV), to improve gene therapies for muscle diseases. https://t.co/wuMSjqu4ch

[Janet Macpherson (she/her) @jmacpher]

BioMolecular Horizons is in Melbourne this coming week26th IUBMB
17th FAOBMB
22nd ComBio
Swing by Cytiva's booth to explore breakthrough solutions and chat with our specialists to shape the future of research together.

https://t.co/qNOydOJ4Gk

[Janet Macpherson (she/her) @jmacpher]

Great commentary on the topic of in vivo CAR T therapy>
Drug developers want to reprogram immune cells directly in the body, opening up new gene therapy frontiers in cancer and autoimmunity. https://t.co/OgtpzAbIa2

[Janet Macpherson (she/her) @jmacpher]

Cytiva is aware that tackling scope 3 emissions can be tough. Suppliers and biopharma companies need to collaborate more closely to make strides in sustainability. Check out our review: https://t.co/GelR4dpy4H.

[Dr Kathryn J @nzkatj]

Oh wow, this is some great news. Need to read the details!

[Janet Macpherson (she/her) @jmacpher]

Enter for the opportunity to have your cell image on the cover of @cytotherapy
Thanks @ISCTglobal

[ISCT @ISCTglobal]

Mark your calendars and start collecting the best images from your lab. Get your cells ready, get creative, capture the beauty of your lab work and share it with the world!

Content opens on August 19, 2024.

Learn more: https://t.co/SgYMy4qd5g

[Kenneth W Witwer (he/him) @KennethWWitwer]

The Guidelines for minimal information on cellular senescence experimentation #MICSE are now available @CellCellPress: "...an overview of senescence markers in rodent tissues, transgenic models, non-mammalian systems, human tissues, and tumors and their use in the identification and specification of senescent cells."
Thanks to the leadership of Mikolaj Ogrodnik, Johannes Grillari, Marco Demaria @marc_dema @LBG_SHoW and arising in part from a productive Wiggers-Bernard conference https://t.co/3FKu12DE7X

[ISCT @ISCTglobal]

The ISCT Early Stage Professionals Committee is looking for dedicated and enthusiastic new members to support current and upcoming programs.

Join our CGT community today to foster global connections and progress your career.

Learn more: https://t.co/xsEcDggswa

[Alicia Didsbury @AliciaD_nz]

Loved the ISCT ANZ poster session! Great opportunity for discussion, networking, and talking about research. So impressed by all the amazing work happening in our region! @ISCTglobal @ISCT_ESP #isctanz2024 #cellandgenetherapy @EmilyBlyth5 @jmacpher @eom_jennifer @bio_ora

[Janet Macpherson (she/her) @jmacpher]

@AliciaD_nz @ISCTglobal @ISCT_ESP @EmilyBlyth5 @eom_jennifer @bio_ora We just need a bit more space

[A/Prof Emily Blyth @EmilyBlyth5]

#ISCTANZ2024 even more spectacular today as the main meeting gets underway.
In the joint @ISCTglobal AND @theASSCR joint session.
Here @jmacpher presents data on non-viral lipid nano particles for gene editing of CD34 stem cells.

[Janet Macpherson (she/her) @jmacpher]

See you next week in Queenstown NZ for #ISCTANZ2024 https://t.co/AhhdjYKTXD

[Janet Macpherson (she/her) @jmacpher]

We've been busy eliminating polystyrene in packaging.

Our new packaging has liners made with renewable paper and corn starch as their primary ingredients.

[Janet Macpherson (she/her) @jmacpher]

Did you miss the future of oligo synthesis? Don't worry, you can now access it on-demand webinar.

Watch now and learn how a unicorn's magic powers can bring you up to speed as quickly as possible: https://t.co/ybF76mmb6D

[Janet Macpherson (she/her) @jmacpher]

Thinking about bringing your oligo process in-house? It's a brave decision. Find out if it is for you

Explore what it entails and the benefits of owning your process in our on-demand webinar.

https://t.co/OZpEHJMCkV

[Janet Macpherson (she/her) @jmacpher]

Calling all ÄKTA oligosynt users! Boost your yields in oligo synthesis in less than 30 minutes with our on-demand webinar. : https://t.co/OHls5zPngx

[Joaquim Vives @xinoxan]

📢 The application #deadline has been extended to 2 July 2024 – apply now!
🏃‍♂️Last chance to join this year’s edition.
🔗 https://t.co/EH3I12sM8V